comparemela.com

Page 17 - Richard Wyse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rickmansworth Parkinson s cure researcher made MBE

Rickmansworth Parkinson s cure researcher made MBE
watfordobserver.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from watfordobserver.co.uk Daily Mail and Mail on Sunday newspapers.

New Year Honours 2024: Kick It Out chairman made MBE

C4XD and Garvan Institute of Medical Research report successful patient stratification approach using C4XD s new precision medicine platform PatientSeek

C4XD and Garvan Institute of Medical Research report successful patient stratification approach using C4XD s new precision medicine platform PatientSeek
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Who s Moving: Amnesty International UK, London s Air Ambulance Charity and more

Who s Moving: Amnesty International UK, London s Air Ambulance Charity and more
civilsociety.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from civilsociety.co.uk Daily Mail and Mail on Sunday newspapers.

AbFero Pharmaceuticals Announces Funding From Cure Parkinson s For Lead Compound SP-420

AbFero Pharmaceuticals Announces Funding From Cure Parkinson s For Lead Compound SP-420 Second Parkinson s Grant to Clinical Stage Pharmaceutical Company Developing Iron Chelators HARWELL, England, Feb. 17, 2021 /PRNewswire/ AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the award of a grant from Cure Parkinson s for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson s disease (PD). The funding will be used to develop biomarkers to demonstrate that SP-420 is an effective targeted therapy for Parkinson s. This is the second grant AbFero has received to support development of SP-420 for the condition, following recent funding from Eureka EUROSTARS.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.